Poll Results: Anti-Influenza Therapy in Community-Acquired Pneumonia
Review the results of a recent reader poll on using anti-influenza therapies in patients with community-acquired pneumonia.
Influenza
Fluad Quadrivalent Influenza Vaccine Approved for Older Adults
The FDA has approved Fluad Quadrivalent (influenza vaccine, adjuvanted; Seqirus) for active immunization in patients 65 years of age and older against influenza disease caused by influenza virus subtypes A and types B contained in the vaccine.
Double-Dose Influenza Vaccine Doses May Not Benefit Pregnant Women With HIV
A double-dose of inactivated influenza vaccine may not increase the immunogenicity of the vaccine among pregnant women with HIV.
ACIP: 2020 Child and Adolescent Immunization Schedule Updates
The ACIP has released an updated version of the child and adolescent immunization schedule for ages 18 years and younger in the United States.
ACIP: 2020 Adult Immunization Schedule Updates
The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has released an updated version of the adult immunization schedule for ages 19 years and older in the United States.
FDA Approves Novel Influenza A (H5N1) Vaccine
The FDA has approved the influenza A H5N1 vaccine for active immunization in patients 6 months of age and older with increased risk of exposure.
Many US Adults Have Misconceptions About Influenza Virus and Vaccination
Only 49% of a national sample of US adults reported having received the flu shot as of December 2019.
Real-Time Flu Surveillance Could Be Improved by Wearable Device Data
Data collected from wearable devices significantly improved the real-time surveillance of influenza-like illness.
Oral Influenza Vaccine Promising Based on Challenge Study Results
Vaxart announced positive topline data from a phase 2 study evaluating the H1 influenza oral tablet vaccine, VXA-A1.1, for the prevention of influenza disease.
Influenza Vaccine for Older Adults Granted Fast Track Status
The Food and Drug Administration has granted Fast Track designation to NanoFlu (Novavax) for seasonal influenza vaccination in adults ≥65 years.
Next post in Influenza
